Trial Profile
An Open Phase II Multi-Center Trial of BAY 59-8862 in Patients With Aggressive Refractory Non-Hodgkin's Lymphoma
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2007
Price :
$35
*
At a glance
- Drugs Ortataxel (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 20 Sep 2007 Status change from suspended to in progress
- 27 Sep 2005 New trial record.